Search - tctmd.com

Displaying 341 - 360 of 817

Sort: Relevancy | Date

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Daily News

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Yael L. Maxwell

December 06, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

FDA Reminds Clinicians About Biotin Interference With Troponin Tests

Todd Neale

November 05, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Daily News

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

Todd Neale

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

Todd Neale

October 10, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Advertisement

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

FDA Reminds Clinicians About Biotin Interference With Troponin Tests

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Repeat Target-Lesion PCI: An Option for Public Reporting?

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

Recurrent Events Common Among Young Patients With CAD

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

TCTMD’s Top 10 Most Popular Stories for September 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content